Intranasal corticosteroid monotherapy in acute rhinosinusitis: an evidence-based case report.
In this evidence-based case report we studied the clinical question: Does intranasal corticosteroid (INCS) monotherapy reduce time to recovery in adults with acute noncomplicated rhinosinusitis? The search yielded 490 papers, of which only two were relevant and had a high validity regarding our clinical question.
Venekamp
Roderick P
RP
Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands. R.P.Venekamp@umcutrecht.nl
Sachs
Alfred P E
AP
Bonten
Marc J M
MJ
Verheij
Theo J M
TJ
van der Heijden
Geert J M G
GJ
Rovers
Maroeska M
MM
D000208:Acute Disease; D000281:Administration, Intranasal; D000328:Adult; D000658:Amoxicillin / Q000008:administration & dosage; D019819:Budesonide / Q000008:administration & dosage; D019317:Evidence-Based Medicine; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D000068656:Mometasone Furoate; D011244:Pregnadienediols / Q000008:administration & dosage; D012220:Rhinitis / Q000188:drug therapy*; D012852:Sinusitis / Q000188:drug therapy*; D016896:Treatment Outcome
D005938:Glucocorticoids; D011244:Pregnadienediols; D000068656:Mometasone Furoate; D019819:Budesonide; D000658:Amoxicillin